Evidence map›Paper›PMID 34812411›Full record

ArticleInformatics in medicine unlocked2021

Genome-wide identification and prediction of SARS-CoV-2 mutations show an abundance of variants: Integrated study of bioinformatics and deep neural learning.

Md Shahadat Hossain, A Q M Sala Uddin Pathan, Md Nur Islam, Mahafujul Islam Quadery Tonmoy, Mahmudul Islam Rakib, Md Adnan Munim, Otun Saha, Atqiya Fariha, Hasan Al Reza, Maitreyee Roy and 2 more

Open access · goldAbstract read
In one paragraph

Article in Informatics in medicine unlocked, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
0.5field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 15 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Mycophenolic acid treatment drives the emergence of novel SARS-CoV-2 variants.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Md Shahadat HossainDepartment of Biotechnology & Genetic Engineering, Noakhali Science and Technology University, Noakhali, Bangladesh.
A Q M Sala Uddin PathanDepartment of Computer Science and Telecommunication Engineering, Noakhali Science and Technology University, Noakhali, Bangladesh.
Md Nur IslamDepartment of Biotechnology & Genetic Engineering, Noakhali Science and Technology University, Noakhali, Bangladesh.
Mahafujul Islam Quadery TonmoyDepartment of Biotechnology & Genetic Engineering, Noakhali Science and Technology University, Noakhali, Bangladesh.
Mahmudul Islam RakibDepartment of Computer Science and Telecommunication Engineering, Noakhali Science and Technology University, Noakhali, Bangladesh.
Md Adnan MunimDepartment of Biotechnology & Genetic Engineering, Noakhali Science and Technology University, Noakhali, Bangladesh.
Otun SahaDepartment of Microbiology, University of Dhaka, Dhaka, Bangladesh.
Atqiya FarihaDepartment of Biotechnology & Genetic Engineering, Noakhali Science and Technology University, Noakhali, Bangladesh.
Hasan Al RezaDepartment of Genetic Engineering and Biotechnology, University of Dhaka, Dhaka, Bangladesh.
Maitreyee RoySchool of Optometry and Vision Science, Faculty of Medicine and Health, University of New South Wales, Bangladesh.
Newaz Mohammed BahadurDepartment of Applied Chemistry and Chemical Engineering, Noakhali Science and Technology University, Noakhali, Bangladesh.
Md Mizanur RahamanDepartment of Microbiology, University of Dhaka, Dhaka, Bangladesh.
Noakhali Science and Technology University · BDUniversity of Dhaka · BDBangladesh University · BD

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Genomic data analysis is a fundamental system for monitoring pathogen evolution and the outbreak of infectious diseases. Based on bioinformatics and deep learning, this study was designed to identify the genomic variability of SARS-CoV-2 worldwide and predict the impending mutation rate. Analysis of 259044 SARS-CoV-2 isolates identified 3334545 mutations with an average of 14.01 mutations per isolate. Globally, single nucleotide polymorphism (SNP) is the most prevalent mutational event. The prevalence of C > T (52.67%) was noticed as a major alteration across the world followed by the G > T (14.59%) and A > G (11.13%). Strains from India showed the highest number of mutations (48) followed by Scotland, USA, Netherlands, Norway, and France having up to 36 mutations. D416G, F106F, P314L, UTR:C241T, L93L, A222V, A199A, V30L, and A220V mutations were found as the most frequent mutations. D1118H, S194L, R262H, M809L, P314L, A8D, S220G, A890D, G1433C, T1456I, R233C, F263S, L111K, A54T, A74V, L183A, A316T, V212F, L46C, V48G, Q57H, W131R, G172V, Q185H, and Y206S missense mutations were found to largely decrease the structural stability of the corresponding proteins. Conversely, D3L, L5F, and S97I were found to largely increase the structural stability of the corresponding proteins. Multi-nucleotide mutations GGG > AAC, CC > TT, TG > CA, and AT > TA have come up in our analysis which are in the top 20 mutational cohort. Future mutation rate analysis predicts a 17%, 7%, and 3% increment of C > T, A > G, and A > T, respectively in the future. Conversely, 7%, 7%, and 6% decrement is estimated for T > C, G > A, and G > T mutations, respectively. T > G\A, C > G\A, and A > T\C are not anticipated in the future. Since SARS-CoV-2 is mutating continuously, our findings will facilitate the tracking of mutations and help to map the progression of the COVID-19 intensity worldwide.

Indexed as

COVID-19Genomic dataMutationMutation rateSARS-CoV-2

Identifiers

PMID34812411
PMCPMC8598266
OpenAlexW3212536238

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.